Table 3 Impact of number of tissues/organs for ICRP Publication 110 voxelized reference phantoms using ICRP Publication 103 tissue weighting factors, wT, to calculate the effective dose coefficient, e, with the SD. The difference in percent calculated according to Eq. 4 and stability according to Eq. 5
Tissue/organ (n = 14) | Effective dose coefficient e (μSv/MBq) | Difference (%) | Stability (%) |
|---|---|---|---|
Muscle | 16.6 ± 3.0 | – | 29.4 |
Spleen | 18.7 ± 2.6 | 30.3 | 20.5 |
Lungs | 19.7 ± 3.3 | 14.7 | 16.2 |
Liver | 20.9 ± 3.6 | 17.7 | 11.0 |
Urinary bladder content | 21.5 ± 3.2 | 8.5 | 8.5 |
Adrenal glands | 22.1 ± 3.4 | 8.2 | 6.1 |
Kidneys | 22.6 ± 3.5 | 7.6 | 3.8 |
Bone marrow (red) | 22.8 ± 3.5 | 3.6 | 2.8 |
Brain | 23.0 ± 3.3 | 2.8 | 2.0 |
Thyroid | 23.2 ± 3.2 | 2.2 | 1.3 |
Salivary glands | 23.3 ± 3.3 | 1.7 | 0.8 |
Heart wall | 23.4 ± 3.4 | 1.6 | 0.4 |
Gonads (testes/ovaries) | 23.5 ± 3.5 | 1.2 | 0.0 |
Pituitary gland | 23.5 ± 3.5 | 0.0 | 0.0 |